Decipher Labs Share Price Today | Stock Price & Decipher Labs Share Screener
As of October 16, 2026, the live Decipher Labs share price (BSE: DECIPHER) is ₹5.52, up 0.36% from the previous close, with shares trading between ₹5.52 and ₹5.71 in today's trading session, and a 52-week range of ₹5.00–₹10.76. Check DECIPHER 52-week chart for the annual price range and momentum. Use the Decipher Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Decipher Labs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Decipher Labs Share Price Chart
Track the current stock price of Decipher Labs with an interactive chart. Analyse DECIPHER share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Decipher Labs stock quote in one place.
The quote of ₹5.52 sits between the 52-week low of ₹5.00 and the 52-week high of ₹10.76, and the latest session moved 0.36% from the previous close.
Decipher Labs Company Profile - Fundamental Screener
Screen Decipher Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DECIPHER shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE643N01012.
Company Details
Classification
Identifiers and Leadership
Decipher Labs Balance Sheet Screener
Screen DECIPHER balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹24, down from ₹26 in 2025.
Latest statistics put total assets at ₹24 and shareholder funds at ₹21, with a leverage ratio of 0.02.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
Assets |
|||||||||
| Total Assets | 24 | 26 | 34 | 28 | 42 | 39 | 35 | 6 | 3 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 2 | 3 | 3 | 3 | 3 | 4 | 5 | 0 | 0 |
Liabilities |
|||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 0 | 7 | 8 | 2 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||||
| Total Equity | 21 | 23 | 22 | 23 | 24 | 14 | 13 | 3 | 2 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 8 | 8 |
| Reserves & Surplus | 11 | 13 | 12 | 13 | 14 | 4 | 3 | -6 | -6 |
Decipher Labs Income Statement Screener - Profit & Revenue Analysis
Screen Decipher Labs income statement and profit fundamentals. Analyze DECIPHER quarterly results. Decipher Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹4 and net profit was ₹0, equal to earnings per unit of ₹-0.35, at an operating margin of 6%.
In that period expenses were ₹3, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹3 and net profit of ₹-2.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 4 | 3 | 4 | 3 | 4 | 3 | 11 | 8 | 6 | 6 | 10 | 10 | 8 | 8 | 24 |
| Expenses | 3 | 5 | 10 | 6 | 4 | 4 | 9 | 6 | 7 | 6 | 14 | 10 | 10 | 8 | 21 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 0 | -2 | -6 | -3 | 0 | 0 | 2 | 2 | -1 | -1 | -4 | 0 | -2 | 0 | 3 |
| Operating Profit % | 6.00% | -90.00% | -188.00% | -114.00% | 3.00% | -13.00% | 11.00% | 18.00% | -23.00% | -11.00% | -39.00% | -1.00% | -29.00% | 2.00% | 11.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 0 | -2 | -6 | -3 | 0 | -1 | 1 | 1 | -1 | -1 | -4 | 0 | -2 | 0 | 3 |
| Tax | 1 | 0 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Net Profit | 0 | -2 | -4 | -3 | 0 | -1 | 1 | 1 | -1 | -1 | -4 | -1 | -2 | 0 | 2 |
| EPS | -0.35 | -2.16 | -4.07 | -3.39 | 0.02 | -0.53 | 1.19 | 0.94 | -1.31 | -0.59 | -4.23 | -0.94 | -1.92 | 0.01 | 1.93 |
Decipher Labs Cash Flow Screener - Liquidity Fundamentals
Screen DECIPHER cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹3, and net cash flow was an outflow of ₹3.
Over the same period, investing activities provided ₹0 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||||
| Operating Activities | -3 | -10 | 5 | -2 | 8 | 2 | -15 | 0 | 0 |
| Investing Activities | 0 | 3 | -2 | -4 | -1 | 0 | 0 | 0 | 0 |
Financing and Net Cash | |||||||||
| Financing Activities | 0 | 0 | -1 | -2 | 1 | 4 | 16 | 0 | 0 |
| Net Cash Flow | -3 | -7 | 2 | -8 | 8 | 6 | 1 | 0 | 0 |
Decipher Labs Shareholding Pattern Screener
See Decipher Labs shareholding pattern with promoter, FII, and DII holdings. Check Decipher Labs promoter holding and ownership changes for DECIPHER on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 16.43%, foreign institutions 0.00%, domestic institutions 0.00% and the public 78.53%, spread across 29,596 shareholders.
The shareholder count was 29,596 in 2026-Mar, compared with 29,368 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2026-Sept | 2025-Dec | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% | 16.43% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 78.53% | 78.52% | 78.51% | 78.48% | 80.75% | 78.76% | 78.73% | 80.43% |
| Other Holding | 5.03% | 5.05% | 5.06% | 5.09% | 2.82% | 4.81% | 4.84% | 3.14% |
| Shareholder Count | 29,596 | 29,368 | 29,213 | 29,825 | 31,182 | 30,512 | 30,174 | 33,371 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Decipher Labs. Decipher Labs dividend yield can be compared with peers and other stocks in the market.
Decipher Labs Stock Index Membership - Nifty & Sensex
See which indices include Decipher Labs stock. Check DECIPHER index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Decipher Labs Market Events Screener - Corporate Actions
Get Decipher Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Decipher Labs stock events that may affect DECIPHER share price, along with derivatives, futures and options activity and sector gainers.
13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 30, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -0.81% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 4.92% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 7.55% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 5.29% |
| 2026-02-12 | 2026-02-12 | Extraordinary General Meeting | NA | -4.56% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -5.53% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 1.45% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -0.73% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.91% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.95% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.57% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -7.24% |
| 2020-02-12 | 2020-02-12 | Change Of Name | NA | 0.00% |
Decipher Labs Competitors Screener - Peer Stocks Comparison
Screen DECIPHER competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,995 | 34.85 | 61,674 | 12.69% | 11,565 | 37.01 |
| Divis Laboratories | 242,758 | 83.68 | 11,067 | 13.95% | 2,568 | 46.92 |
| Torrent Pharmaceuticals | 173,406 | 80.45 | 13,886 | 20.34% | 2,138 | 32.77 |
| Zydus Life Science | 112,020 | 24.42 | 27,658 | 17.64% | 5,026 | 44.73 |
| Laurus Labs | 111,310 | 102.03 | 6,868 | 22.01% | 890 | 60.45 |
| Cipla | 107,049 | 31.90 | 29,045 | 2.24% | 3,870 | 40.32 |
| Dr Reddys Laboratories | 102,916 | 32.30 | 35,059 | 3.90% | 4,158 | 57.84 |
| Aurobindo Pharma | 95,910 | 25.74 | 34,145 | 5.56% | 3,503 | 47.98 |
| Mankind Pharma | 93,988 | 45.45 | 14,636 | 14.85% | 1,938 | 37.77 |
| Lupin | 89,702 | 16.11 | 29,039 | 26.75% | 5,356 | 35.35 |
Decipher Labs Company Announcements - News & Reports Screener
Screen DECIPHER latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 15, 2026.
The next most recent announcements are dated September 30, 2026 and September 30, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-29 | Closure of Trading Window | - |
| 2026-09-09 | Newspaper Advertisement For AGM Notice For The Financial Year 2025-26. | - |
| 2026-09-08 | Intimation Of Book Closure And Cut Off Date For Annual General Meeting | - |
| 2026-09-08 | Reg. 34 (1) Annual Report. | - |
| 2026-09-08 | Notice Of 40Th Annual General Meeting For The Financial Year 2025-26 Under Regulation 34 Of SEBI (LODR) Regulation 2015. | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On 05.09.2026. | - |
| 2026-08-14 | Announcements Under Regulation 30 Of SEBI (LODR) Regulations 2015. | - |
| 2026-08-13 | Revised Un-Audited Financial Results For The Quarter Ended 30.06.2026. | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-08-13 | Financial Results For The Quarter Ended 30.06.2026. | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-06 | Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August 2026. | - |
| 2026-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-24 | Closure of Trading Window | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-30 | Audited Standalone And Consolidated Financial Results & Statements For The Quarter And Year Ended 31.03.2026 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5.52, within a 52-week range of ₹5.00 to ₹10.76. The P/E ratio is -1.82 and the P/B ratio is 0.27, with earnings per unit of ₹-3.05. Market capitalisation stands at ₹5.60 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 19, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.